AI-enabled platform for automating cancer trial candidate identification
Economics of Care
Fund
Fund I
entry
2018
exit
2022
ACQUIRED BY
Tamarind Hill Team
No items found.
About
Deep Lens
Deep Lens automates the identification of candidates for cancer trials through its AI-enabled digital pathology workflow platform. By corresponding lab and patient data, the Deep Lens platform, VIPER, speeds trial completion and makes connections to the “right trial for the right patient at the right time”.
Meet the
Deep Lens
team
Dave Billiter
Co-founder and CEO
TJ Bowen
Co-founder and COO
Simon Arkell
Co-founder and President
Join
Deep Lens
Interested in joining the team? Check out open positions across our portfolio here.
Medicine
5
min read
The Impact of IoT on B2B Healthcare Medicine
Exploring Cutting-Edge Technologies Driving the Healthcare Industry Forward
Explore other portfolio companies that we proudly partner with
Your partners on the path to B2B Healthcare Innovation.
Founders
Get on our radar
Investors
Connect with us
Advisors
Join our network
Partners
Collaborate with us
